| Company |
Business Area |
Product |
Indication |
Feasibility |
Pre-clinical |
Phase 1 |
Phase 2 |
Phase 3 |
Remark |
| Reasearch |
Development |
Proof of Concept |
Pilot Study |
Pivotal Study |
| Algokbio |
Cancer therapeutics |
| TM4SF4 antibody therapy |
AGK-102 |
Lung / Liver / Pancreatic cancer |
1 |
1 |
|
|
|
First-in-class cancer stem cell biomarker target |
| BIXINK |
HER2 targeted therapy |
NERLYNX® |
Early breast cancer |
1 |
1 |
1 |
1 |
1 |
MFDS Approval, 4Q 2021 / Launch, 1Q 2022 |
| Cancer supportive care |
Adhesion fluid-gel type wound dressing |
Mucosamin TM |
Radio/Chemotherapy-induced mucositis and dry mouth |
1 |
1 |
1 |
1 |
1 |
MFDS regulatory submission |
| Digital therapeutics |
Exposure and response prevention |
OC Free® |
Obsessive compulsive disorder |
1 |
1 |
1 |
1 |
|
|
| Cognitive behavioral therapy |
SparkRx TM |
Adolescent depression |
1 |
1 |
1 |
1 |
|
|
| Cognitive behavioral stress management |
attune TM |
Cancer-related symptoms of anxiety and depression |
1 |
1 |
1 |
1 |
|
Breakthrough device designation by FDA, 2020 |
| DreAMLand TM |
Cancer-related symptoms of anxiety and depression(AML-specific) |
1 |
1 |
1 |
1 |
|
Breakthrough device designation by FDA, 2022 |
| Digital healthcare management |
Symptom tracking and medication management |
WEPEACH® |
Breast cancer patients supportive care |
1 |
1 |
1 |
1 |
1 |
Launch, 2Q 2021 |
| KPS BIO |
Diagnostics |
Multiple biomarker panel |
KPS-101 |
Early diagnosis of hepatocellular carcinoma |
1 |
1 |
1 |
1 |
|
Published in SCI-E journal, 2Q 2022 |
| Companion diagnostics |
KPS-102 |
Blood cancer |
1 |
|
|
|
|
|
| KPS-103 |
Lung cancer(TM4SF4) |
1 |
|
|
|
|
|
| Circulating tumor cell isolation |
KPS-104 |
Automation equipment(Label-dependent) |
1 |
1 |
|
|
|
|
| KPS-105 |
Automation equipment(Label-free) |
1 |
1 |
|
|
|
|
| CDMO |
Incrementally modified drug |
KPT-101 |
Inflammatory bowel disease |
1 |
|
|
|
|
|
| First generic |
KPT-102 |
Irritable bowel syndrome with constipation |
1 |
|
|
|
|
|
| KPT-103 |
Irritable bowel syndrome with diarrhea |
1 |
|
|
|
|
|
| KPT-104 |
Idiopathic pulmonary fibrosis |
1 |
|
|
|
|
|
